Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran ABPM Study in Fibromyalgia
NCT00618956Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Oct 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia (FM), sponsored by Forest Laboratories. Started Oct 2007; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00618956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618956.